Review of qualitative study on AFP surveillance sustainability in Ethiopia from 1996 to 2018
Ethiopia keeps polio watch despite funding cuts and hard terrain
This qualitative review examines factors affecting acute flaccid paralysis surveillance sustainability in Ethiopia between 1996 and 2018. Th…
Ethiopia's polio watch relies on brave locals who adapt when outside funds dry up, but long-term survival needs more homegrown investment.
Surveillance report describes poliovirus data from 40 high-risk countries
Global health report describes polio surveillance in 40 high-risk countries
A surveillance report describes poliovirus data from 40 outbreak and high-risk priority countries worldwide. No specific interventions, outc…
A global health report describes how polio is being monitored in 40 high-risk countries using surveillance data collected between 2018 and 2…
Surveillance analysis identifies areas with high risk for poliovirus transmission
Where is polio still a threat? New surveillance data tracks high-risk areas.
A surveillance analysis of acute flaccid paralysis data identified areas worldwide with high risk for poliovirus transmission. The report do…
Polio still lingers in some parts of the world, and new surveillance data tracks high-risk areas to help health workers focus vaccination ef…
COVID-19 immunization disruptions elevate polio risk in Africa and the Philippines
Did pandemic disruptions put kids at higher risk for polio?
A report describes how disruptions to routine immunizations during the COVID-19 pandemic have elevated the risk for increases in vaccine-pre…
Pandemic disruptions to childhood vaccines in Africa and the Philippines have raised the risk for outbreaks of dangerous diseases like polio…
New 6-in-1 infant vaccine licensed but availability delayed until at least 2021
New six-in-one vaccine for infants receives regulatory approval
A new combination vaccine for infants targeting diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B has received licensure. Key stud…
A new six-in-one vaccine for infants has received regulatory approval, but it won't be available for use until 2021 or later.